← Open Payments lookup

ANDREW KERSTEIN: Open Payments

NPI 1346473360 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,636 in 84 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $665 · 2025 $1,636

Food & beverage: $1,636
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$319
Teva Pharmaceuticals USA, Inc.25$315
E.R. Squibb & Sons, L.L.C.11$308
Otsuka America Pharmaceutical, Inc.12$191
Alkermes, Inc.4$107
Almatica Pharma LLC5$97
Noven Therapeutics, LLC3$61
Axsome Therapeutics, Inc.3$56
ABBVIE INC.2$45
ACADIA Pharmaceuticals Inc2$41

Products named: INGREZZA, AUSTEDO XR, COBENFY, REXULTI, ARISTADA, LOREEV XR, Xelstrym, Auvelity.

Industry payments across MO — which companies pay providers there.